Today: 21 January 2026
Subscribe
Browse Category

NASDAQ:NVAX News 20 January 2026 - 21 January 2026

Novavax stock edges up premarket as Pfizer Matrix‑M pact puts $530 million-plus in play

Novavax stock edges up premarket as Pfizer Matrix‑M pact puts $530 million-plus in play

New York, January 21, 2026, 05:22 EST — Premarket Novavax shares edged higher by about 1% in premarket Wednesday after announcing a licensing agreement with Pfizer for its Matrix‑M vaccine technology. The stock last changed hands at $8.28, marking a 0.98% increase. (Public) Novavax’s deal is significant as the company looks to pivot its platform toward steadier revenue sources amid…
21 January 2026
······
Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

New York, January 20, 2026, 14:46 EST — During the regular session Pfizer (PFE) shares slipped 0.7% to $25.47 Tuesday afternoon, after GSK and Shionogi announced Pfizer will exit HIV-focused ViiV Healthcare in a $1.9 billion deal. Pfizer is set to get $1.88 billion for its 11.7% stake, with the deal expected to close in Q1 pending regulatory approval. That…
20 January 2026
······

Stock Market Today

  • U.S. Futures Slide as Gold Climbs Ahead of Trump's Davos Address
    January 21, 2026, 10:04 AM EST. U.S. stock futures edged lower in early trading while gold prices hit a fresh record, reflecting cautious investor sentiment ahead of former President Donald Trump's speech at the World Economic Forum in Davos. Futures contracts for major U.S. indices, including the S&P 500 and Nasdaq, showed modest declines as markets awaited cues from Trump's address, which could influence economic and geopolitical outlooks. Meanwhile, gold, considered a safe-haven asset, surged to a new high on tightening market jitters. Traders are balancing risk appetite with uncertainty, positioning cautiously before the high-profile event. Market participants will closely monitor the speech for policy insights amid ongoing global economic challenges and geopolitical tensions.
Go toTop